Menu

New Ebola Outbreak in Democratic Republic of Congo

Four of six samples from the North Kivu province have tested positive for the virus.

Aug 2, 2018
Sukanya Charuchandra

ABOVE: ©ISTOCK, HENRIK5000

A mere week after health officials declared the end of Democratic Republic of Congo’s ninth Ebola outbreak since 1976, a “cluster of presumptive Ebola cases” have surfaced in the country, according to the World Health Organization

The Democratic Republic of Congo (DRC) Ministry of Health informed the World Health Organization (WHO) yesterday (August 1) of six possible cases, four of which have come back positive for Ebola virus, although the species responsible remains unclear. These cases follow a July 28 report of 26 cases (including 20 deaths) with indications of hemorrhagic fever. 

This outbreak is more than 1,500 miles from the earlier one on the opposite side of the country. “It’s unlikely to be connected to the previous outbreak,” Jessica Ilunga, a spokeswoman for DRC Health Minister Oly Ilunga, tells STAT News

See “End May Be in Sight for Ebola Outbreak in Central Africa

The cases all occurred in a DRC province called North Kivu that borders Rwanda and Uganda. Travel through the village of Mangina, where the majority of the cases are from, has been barred, according to The Washington Post

Health workers have raised concerns about the potential for the outbreak to spread, as Mangina is only 18 miles west of Beni, a center of trade. “Beni has been deeply unstable for the past few years due to armed conflict and Ebola poses a serious risk to communities already on the edge, and threatens our ability to help them,” Jose Barahona, the charity organization Oxfam’s country director for DRC, tells The Guardian. “This outbreak comes at a time when the country is already unstable, with millions of people caught up in humanitarian crises as a result of ongoing conflicts.”

See “Experimental Ebola Vaccine to be Used in DRC Outbreak

The WHO is carrying out additional testing and will be working with neighboring countries to prepare them for any possibility, according to CNN.  Fortunately, equipment and responders to the earlier outbreak are still in DRC. “This allows us to have a head start in response to this cluster,” Matshidiso Moeti, the WHO’s regional director for Africa, says in the organization’s statement. 

In addition, 12 Ministry of Health experts including epidemiologists and doctors will travel to Beni with a mobile laboratory and protective equipment from the National Institute of Biomedical Research in Kinshasa.

See “New Species of Ebola Discovered

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.